BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29893051)

  • 21. A randomized, half-side comparative study of aminolaevulinate photodynamic therapy vs. CO(2) laser ablation in immunocompetent patients with multiple actinic keratoses.
    Scola N; Terras S; Georgas D; Othlinghaus N; Matip R; Pantelaki I; Möllenhoff K; Stücker M; Altmeyer P; Kreuter A; Gambichler T
    Br J Dermatol; 2012 Dec; 167(6):1366-73. PubMed ID: 22708798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study.
    Boone MA; Norrenberg S; Jemec GB; Del Marmol V
    Exp Dermatol; 2013 Feb; 22(2):93-7. PubMed ID: 23301958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Imaging of actinic porokeratosis by optical coherence tomography (OCT)].
    von Felbert V; Neis M; Megahed M; Spöler F
    Hautarzt; 2008 Nov; 59(11):877-9. PubMed ID: 18931984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryosurgery treatment of actinic keratoses monitored by optical coherence tomography: a pilot study.
    Themstrup L; Banzhaf C; Mogensen M; Jemec GB
    Dermatology; 2012; 225(3):242-7. PubMed ID: 23183492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Actinic Keratosis].
    Dejaco D; Hauser U; Zelger B; Riechelmann H
    Laryngorhinootologie; 2015 Jul; 94(7):467-79; quiz 480-1. PubMed ID: 26125293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound.
    Mogensen M; Nürnberg BM; Forman JL; Thomsen JB; Thrane L; Jemec GB
    Br J Dermatol; 2009 May; 160(5):1026-33. PubMed ID: 19183171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
    Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are actinic keratoses really squamous cell cancer? How do we know if they would become malignant?
    Conforti C; Beninati E; Dianzani C
    Clin Dermatol; 2018; 36(3):430-432. PubMed ID: 29908585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
    Filosa A; Filosa G
    G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Fingerprinting" Benign and Cancerous Skin Lesions Using Vibrational Optical Coherence Tomography: Differentiation among Cancerous Lesion Types Based on the Presence of New Cells, Blood Vessels, and Fibrosis.
    Silver FH; Deshmukh T; Ryan N; Romm A; Nadiminti H
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo measurements of blood vessels' distribution in non-melanoma skin cancer by dynamic optical coherence tomography - a new quantitative measure?
    Sigsgaard V; Themstrup L; Theut Riis P; Olsen J; Jemec GB
    Skin Res Technol; 2018 Feb; 24(1):123-128. PubMed ID: 28771885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [When and why treat actinic keratoses?].
    Wulf HC
    Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspective on actinic keratosis: a review.
    Siegel JA; Korgavkar K; Weinstock MA
    Br J Dermatol; 2017 Aug; 177(2):350-358. PubMed ID: 27500794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
    Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic grading and treatment of facial actinic keratosis.
    Zalaudek I; Piana S; Moscarella E; Longo C; Zendri E; Castagnetti F; Pellacani G; Lallas A; Argenziano G
    Clin Dermatol; 2014; 32(1):80-7. PubMed ID: 24314380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.